There have been significant innovations in the field of biomanufacturing during the last decade. Adopting single-use technologies has been one of the most important advancements in the Biomanufacturing field, which has enabled customers to produce patient-critical therapeutics faster, in large quantities and on time.
The adoption of Single-Use technologies has advanced protein-based Biomanufacturing capabilities and Vaccines, Gene Therapy and mRNA-based Biologics. The advancement and adoption of these new technologies have also created challenges and put significant pressure on the supply chain of Single-Use products.
The set-up of Ekuse facility by PharmNXT Biotech is aimed at alleviating these supply chain challenges and making sure that the supply of Single-Use products to customers is done in the shortest time while maintaining the highest quality standards.
The equipment and consumables provided by PharmNXT Biotech under the Single-Use Technologies portfolio are as follows :
